Pharma & Healthcare
Global Renal Cortical Necrosis Treatment Market Research Report 2025
- Mar 11, 25
- ID: 29541
- Pages: 71
- Figures: 77
- Views: 12
The global market for Renal Cortical Necrosis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Renal cortical necrosis is a rare but severe condition in which there is death (necrosis) of the renal cortex, which is the outer part of the kidney that contains the filtering units (nephrons). This condition is typically caused by a severe disruption of blood flow to the kidneys, often due to various underlying medical conditions or traumatic events. Treatment for renal cortical necrosis is challenging and primarily focuses on addressing the underlying cause and managing the associated complications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Renal Cortical Necrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Cortical Necrosis Treatment.
The Renal Cortical Necrosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Renal Cortical Necrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Renal Cortical Necrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan plc
Amgen Inc.
AstraZeneca plc
Baxter
Keryx Biopharmaceuticals, Inc
Teva Pharmaceutical Limited Inc
Pfizer
Novartis AG
Eisai Pharmaceuticals India Pvt. Ltd.
Segment by Type
Prednisolone
Aspirin
Sodium Bicarbonates
N-acetyl Cysteine
Statins
Others
Segment by Application
Hospitals
Cancer clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Renal Cortical Necrosis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Renal cortical necrosis is a rare but severe condition in which there is death (necrosis) of the renal cortex, which is the outer part of the kidney that contains the filtering units (nephrons). This condition is typically caused by a severe disruption of blood flow to the kidneys, often due to various underlying medical conditions or traumatic events. Treatment for renal cortical necrosis is challenging and primarily focuses on addressing the underlying cause and managing the associated complications.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Renal Cortical Necrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Cortical Necrosis Treatment.
The Renal Cortical Necrosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Renal Cortical Necrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Renal Cortical Necrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan plc
Amgen Inc.
AstraZeneca plc
Baxter
Keryx Biopharmaceuticals, Inc
Teva Pharmaceutical Limited Inc
Pfizer
Novartis AG
Eisai Pharmaceuticals India Pvt. Ltd.
Segment by Type
Prednisolone
Aspirin
Sodium Bicarbonates
N-acetyl Cysteine
Statins
Others
Segment by Application
Hospitals
Cancer clinics
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Renal Cortical Necrosis Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Cortical Necrosis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prednisolone
1.2.3 Aspirin
1.2.4 Sodium Bicarbonates
1.2.5 N-acetyl Cysteine
1.2.6 Statins
1.2.7 Others
1.3 Market by Application
1.3.1 Global Renal Cortical Necrosis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Cancer clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Cortical Necrosis Treatment Market Perspective (2020-2031)
2.2 Global Renal Cortical Necrosis Treatment Growth Trends by Region
2.2.1 Global Renal Cortical Necrosis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Renal Cortical Necrosis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Renal Cortical Necrosis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Renal Cortical Necrosis Treatment Market Dynamics
2.3.1 Renal Cortical Necrosis Treatment Industry Trends
2.3.2 Renal Cortical Necrosis Treatment Market Drivers
2.3.3 Renal Cortical Necrosis Treatment Market Challenges
2.3.4 Renal Cortical Necrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Cortical Necrosis Treatment Players by Revenue
3.1.1 Global Top Renal Cortical Necrosis Treatment Players by Revenue (2020-2025)
3.1.2 Global Renal Cortical Necrosis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Renal Cortical Necrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Renal Cortical Necrosis Treatment Revenue
3.4 Global Renal Cortical Necrosis Treatment Market Concentration Ratio
3.4.1 Global Renal Cortical Necrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Cortical Necrosis Treatment Revenue in 2024
3.5 Global Key Players of Renal Cortical Necrosis Treatment Head office and Area Served
3.6 Global Key Players of Renal Cortical Necrosis Treatment, Product and Application
3.7 Global Key Players of Renal Cortical Necrosis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Cortical Necrosis Treatment Breakdown Data by Type
4.1 Global Renal Cortical Necrosis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Renal Cortical Necrosis Treatment Forecasted Market Size by Type (2026-2031)
5 Renal Cortical Necrosis Treatment Breakdown Data by Application
5.1 Global Renal Cortical Necrosis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Renal Cortical Necrosis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Renal Cortical Necrosis Treatment Market Size (2020-2031)
6.2 North America Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Renal Cortical Necrosis Treatment Market Size by Country (2020-2025)
6.4 North America Renal Cortical Necrosis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Cortical Necrosis Treatment Market Size (2020-2031)
7.2 Europe Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Renal Cortical Necrosis Treatment Market Size by Country (2020-2025)
7.4 Europe Renal Cortical Necrosis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Cortical Necrosis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Renal Cortical Necrosis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Cortical Necrosis Treatment Market Size (2020-2031)
9.2 Latin America Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Renal Cortical Necrosis Treatment Market Size by Country (2020-2025)
9.4 Latin America Renal Cortical Necrosis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Cortical Necrosis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan plc
11.1.1 Allergan plc Company Details
11.1.2 Allergan plc Business Overview
11.1.3 Allergan plc Renal Cortical Necrosis Treatment Introduction
11.1.4 Allergan plc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.1.5 Allergan plc Recent Development
11.2 Amgen Inc.
11.2.1 Amgen Inc. Company Details
11.2.2 Amgen Inc. Business Overview
11.2.3 Amgen Inc. Renal Cortical Necrosis Treatment Introduction
11.2.4 Amgen Inc. Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.2.5 Amgen Inc. Recent Development
11.3 AstraZeneca plc
11.3.1 AstraZeneca plc Company Details
11.3.2 AstraZeneca plc Business Overview
11.3.3 AstraZeneca plc Renal Cortical Necrosis Treatment Introduction
11.3.4 AstraZeneca plc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.3.5 AstraZeneca plc Recent Development
11.4 Baxter
11.4.1 Baxter Company Details
11.4.2 Baxter Business Overview
11.4.3 Baxter Renal Cortical Necrosis Treatment Introduction
11.4.4 Baxter Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.4.5 Baxter Recent Development
11.5 Keryx Biopharmaceuticals, Inc
11.5.1 Keryx Biopharmaceuticals, Inc Company Details
11.5.2 Keryx Biopharmaceuticals, Inc Business Overview
11.5.3 Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Introduction
11.5.4 Keryx Biopharmaceuticals, Inc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.5.5 Keryx Biopharmaceuticals, Inc Recent Development
11.6 Teva Pharmaceutical Limited Inc
11.6.1 Teva Pharmaceutical Limited Inc Company Details
11.6.2 Teva Pharmaceutical Limited Inc Business Overview
11.6.3 Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Introduction
11.6.4 Teva Pharmaceutical Limited Inc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.6.5 Teva Pharmaceutical Limited Inc Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Renal Cortical Necrosis Treatment Introduction
11.7.4 Pfizer Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Renal Cortical Necrosis Treatment Introduction
11.8.4 Novartis AG Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.8.5 Novartis AG Recent Development
11.9 Eisai Pharmaceuticals India Pvt. Ltd.
11.9.1 Eisai Pharmaceuticals India Pvt. Ltd. Company Details
11.9.2 Eisai Pharmaceuticals India Pvt. Ltd. Business Overview
11.9.3 Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Introduction
11.9.4 Eisai Pharmaceuticals India Pvt. Ltd. Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.9.5 Eisai Pharmaceuticals India Pvt. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Cortical Necrosis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prednisolone
1.2.3 Aspirin
1.2.4 Sodium Bicarbonates
1.2.5 N-acetyl Cysteine
1.2.6 Statins
1.2.7 Others
1.3 Market by Application
1.3.1 Global Renal Cortical Necrosis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Cancer clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Cortical Necrosis Treatment Market Perspective (2020-2031)
2.2 Global Renal Cortical Necrosis Treatment Growth Trends by Region
2.2.1 Global Renal Cortical Necrosis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Renal Cortical Necrosis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Renal Cortical Necrosis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Renal Cortical Necrosis Treatment Market Dynamics
2.3.1 Renal Cortical Necrosis Treatment Industry Trends
2.3.2 Renal Cortical Necrosis Treatment Market Drivers
2.3.3 Renal Cortical Necrosis Treatment Market Challenges
2.3.4 Renal Cortical Necrosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Cortical Necrosis Treatment Players by Revenue
3.1.1 Global Top Renal Cortical Necrosis Treatment Players by Revenue (2020-2025)
3.1.2 Global Renal Cortical Necrosis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Renal Cortical Necrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Renal Cortical Necrosis Treatment Revenue
3.4 Global Renal Cortical Necrosis Treatment Market Concentration Ratio
3.4.1 Global Renal Cortical Necrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Cortical Necrosis Treatment Revenue in 2024
3.5 Global Key Players of Renal Cortical Necrosis Treatment Head office and Area Served
3.6 Global Key Players of Renal Cortical Necrosis Treatment, Product and Application
3.7 Global Key Players of Renal Cortical Necrosis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Cortical Necrosis Treatment Breakdown Data by Type
4.1 Global Renal Cortical Necrosis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Renal Cortical Necrosis Treatment Forecasted Market Size by Type (2026-2031)
5 Renal Cortical Necrosis Treatment Breakdown Data by Application
5.1 Global Renal Cortical Necrosis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Renal Cortical Necrosis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Renal Cortical Necrosis Treatment Market Size (2020-2031)
6.2 North America Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Renal Cortical Necrosis Treatment Market Size by Country (2020-2025)
6.4 North America Renal Cortical Necrosis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Cortical Necrosis Treatment Market Size (2020-2031)
7.2 Europe Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Renal Cortical Necrosis Treatment Market Size by Country (2020-2025)
7.4 Europe Renal Cortical Necrosis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Cortical Necrosis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Renal Cortical Necrosis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Cortical Necrosis Treatment Market Size (2020-2031)
9.2 Latin America Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Renal Cortical Necrosis Treatment Market Size by Country (2020-2025)
9.4 Latin America Renal Cortical Necrosis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Cortical Necrosis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Renal Cortical Necrosis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan plc
11.1.1 Allergan plc Company Details
11.1.2 Allergan plc Business Overview
11.1.3 Allergan plc Renal Cortical Necrosis Treatment Introduction
11.1.4 Allergan plc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.1.5 Allergan plc Recent Development
11.2 Amgen Inc.
11.2.1 Amgen Inc. Company Details
11.2.2 Amgen Inc. Business Overview
11.2.3 Amgen Inc. Renal Cortical Necrosis Treatment Introduction
11.2.4 Amgen Inc. Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.2.5 Amgen Inc. Recent Development
11.3 AstraZeneca plc
11.3.1 AstraZeneca plc Company Details
11.3.2 AstraZeneca plc Business Overview
11.3.3 AstraZeneca plc Renal Cortical Necrosis Treatment Introduction
11.3.4 AstraZeneca plc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.3.5 AstraZeneca plc Recent Development
11.4 Baxter
11.4.1 Baxter Company Details
11.4.2 Baxter Business Overview
11.4.3 Baxter Renal Cortical Necrosis Treatment Introduction
11.4.4 Baxter Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.4.5 Baxter Recent Development
11.5 Keryx Biopharmaceuticals, Inc
11.5.1 Keryx Biopharmaceuticals, Inc Company Details
11.5.2 Keryx Biopharmaceuticals, Inc Business Overview
11.5.3 Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Introduction
11.5.4 Keryx Biopharmaceuticals, Inc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.5.5 Keryx Biopharmaceuticals, Inc Recent Development
11.6 Teva Pharmaceutical Limited Inc
11.6.1 Teva Pharmaceutical Limited Inc Company Details
11.6.2 Teva Pharmaceutical Limited Inc Business Overview
11.6.3 Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Introduction
11.6.4 Teva Pharmaceutical Limited Inc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.6.5 Teva Pharmaceutical Limited Inc Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Renal Cortical Necrosis Treatment Introduction
11.7.4 Pfizer Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Renal Cortical Necrosis Treatment Introduction
11.8.4 Novartis AG Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.8.5 Novartis AG Recent Development
11.9 Eisai Pharmaceuticals India Pvt. Ltd.
11.9.1 Eisai Pharmaceuticals India Pvt. Ltd. Company Details
11.9.2 Eisai Pharmaceuticals India Pvt. Ltd. Business Overview
11.9.3 Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Introduction
11.9.4 Eisai Pharmaceuticals India Pvt. Ltd. Revenue in Renal Cortical Necrosis Treatment Business (2020-2025)
11.9.5 Eisai Pharmaceuticals India Pvt. Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Renal Cortical Necrosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prednisolone
Table 3. Key Players of Aspirin
Table 4. Key Players of Sodium Bicarbonates
Table 5. Key Players of N-acetyl Cysteine
Table 6. Key Players of Statins
Table 7. Key Players of Others
Table 8. Global Renal Cortical Necrosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Renal Cortical Necrosis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Renal Cortical Necrosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Renal Cortical Necrosis Treatment Market Share by Region (2020-2025)
Table 12. Global Renal Cortical Necrosis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Renal Cortical Necrosis Treatment Market Share by Region (2026-2031)
Table 14. Renal Cortical Necrosis Treatment Market Trends
Table 15. Renal Cortical Necrosis Treatment Market Drivers
Table 16. Renal Cortical Necrosis Treatment Market Challenges
Table 17. Renal Cortical Necrosis Treatment Market Restraints
Table 18. Global Renal Cortical Necrosis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Renal Cortical Necrosis Treatment Market Share by Players (2020-2025)
Table 20. Global Top Renal Cortical Necrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Cortical Necrosis Treatment as of 2024)
Table 21. Ranking of Global Top Renal Cortical Necrosis Treatment Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Renal Cortical Necrosis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Renal Cortical Necrosis Treatment, Headquarters and Area Served
Table 24. Global Key Players of Renal Cortical Necrosis Treatment, Product and Application
Table 25. Global Key Players of Renal Cortical Necrosis Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Renal Cortical Necrosis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Renal Cortical Necrosis Treatment Revenue Market Share by Type (2020-2025)
Table 29. Global Renal Cortical Necrosis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Renal Cortical Necrosis Treatment Revenue Market Share by Type (2026-2031)
Table 31. Global Renal Cortical Necrosis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Renal Cortical Necrosis Treatment Revenue Market Share by Application (2020-2025)
Table 33. Global Renal Cortical Necrosis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Renal Cortical Necrosis Treatment Revenue Market Share by Application (2026-2031)
Table 35. North America Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Renal Cortical Necrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Renal Cortical Necrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Renal Cortical Necrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Renal Cortical Necrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Renal Cortical Necrosis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Renal Cortical Necrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Renal Cortical Necrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 50. Allergan plc Company Details
Table 51. Allergan plc Business Overview
Table 52. Allergan plc Renal Cortical Necrosis Treatment Product
Table 53. Allergan plc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 54. Allergan plc Recent Development
Table 55. Amgen Inc. Company Details
Table 56. Amgen Inc. Business Overview
Table 57. Amgen Inc. Renal Cortical Necrosis Treatment Product
Table 58. Amgen Inc. Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 59. Amgen Inc. Recent Development
Table 60. AstraZeneca plc Company Details
Table 61. AstraZeneca plc Business Overview
Table 62. AstraZeneca plc Renal Cortical Necrosis Treatment Product
Table 63. AstraZeneca plc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 64. AstraZeneca plc Recent Development
Table 65. Baxter Company Details
Table 66. Baxter Business Overview
Table 67. Baxter Renal Cortical Necrosis Treatment Product
Table 68. Baxter Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 69. Baxter Recent Development
Table 70. Keryx Biopharmaceuticals, Inc Company Details
Table 71. Keryx Biopharmaceuticals, Inc Business Overview
Table 72. Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Product
Table 73. Keryx Biopharmaceuticals, Inc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 74. Keryx Biopharmaceuticals, Inc Recent Development
Table 75. Teva Pharmaceutical Limited Inc Company Details
Table 76. Teva Pharmaceutical Limited Inc Business Overview
Table 77. Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Product
Table 78. Teva Pharmaceutical Limited Inc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 79. Teva Pharmaceutical Limited Inc Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Renal Cortical Necrosis Treatment Product
Table 83. Pfizer Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Novartis AG Company Details
Table 86. Novartis AG Business Overview
Table 87. Novartis AG Renal Cortical Necrosis Treatment Product
Table 88. Novartis AG Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 89. Novartis AG Recent Development
Table 90. Eisai Pharmaceuticals India Pvt. Ltd. Company Details
Table 91. Eisai Pharmaceuticals India Pvt. Ltd. Business Overview
Table 92. Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Product
Table 93. Eisai Pharmaceuticals India Pvt. Ltd. Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 94. Eisai Pharmaceuticals India Pvt. Ltd. Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Authors List of This Report
List of Figures
Figure 1. Renal Cortical Necrosis Treatment Picture
Figure 2. Global Renal Cortical Necrosis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Renal Cortical Necrosis Treatment Market Share by Type: 2024 VS 2031
Figure 4. Prednisolone Features
Figure 5. Aspirin Features
Figure 6. Sodium Bicarbonates Features
Figure 7. N-acetyl Cysteine Features
Figure 8. Statins Features
Figure 9. Others Features
Figure 10. Global Renal Cortical Necrosis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Renal Cortical Necrosis Treatment Market Share by Application: 2024 VS 2031
Figure 12. Hospitals Case Studies
Figure 13. Cancer clinics Case Studies
Figure 14. Ambulatory Surgical Centers Case Studies
Figure 15. Others Case Studies
Figure 16. Renal Cortical Necrosis Treatment Report Years Considered
Figure 17. Global Renal Cortical Necrosis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Renal Cortical Necrosis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Renal Cortical Necrosis Treatment Market Share by Region: 2024 VS 2031
Figure 20. Global Renal Cortical Necrosis Treatment Market Share by Players in 2024
Figure 21. Global Top Renal Cortical Necrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Cortical Necrosis Treatment as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Renal Cortical Necrosis Treatment Revenue in 2024
Figure 23. North America Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Renal Cortical Necrosis Treatment Market Share by Country (2020-2031)
Figure 25. United States Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Renal Cortical Necrosis Treatment Market Share by Country (2020-2031)
Figure 29. Germany Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Renal Cortical Necrosis Treatment Market Share by Region (2020-2031)
Figure 37. China Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Renal Cortical Necrosis Treatment Market Share by Country (2020-2031)
Figure 45. Mexico Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Renal Cortical Necrosis Treatment Market Share by Country (2020-2031)
Figure 49. Turkey Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Allergan plc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 53. Amgen Inc. Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 54. AstraZeneca plc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 55. Baxter Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 56. Keryx Biopharmaceuticals, Inc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 57. Teva Pharmaceutical Limited Inc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 59. Novartis AG Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 60. Eisai Pharmaceuticals India Pvt. Ltd. Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Renal Cortical Necrosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prednisolone
Table 3. Key Players of Aspirin
Table 4. Key Players of Sodium Bicarbonates
Table 5. Key Players of N-acetyl Cysteine
Table 6. Key Players of Statins
Table 7. Key Players of Others
Table 8. Global Renal Cortical Necrosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Renal Cortical Necrosis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Renal Cortical Necrosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Renal Cortical Necrosis Treatment Market Share by Region (2020-2025)
Table 12. Global Renal Cortical Necrosis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Renal Cortical Necrosis Treatment Market Share by Region (2026-2031)
Table 14. Renal Cortical Necrosis Treatment Market Trends
Table 15. Renal Cortical Necrosis Treatment Market Drivers
Table 16. Renal Cortical Necrosis Treatment Market Challenges
Table 17. Renal Cortical Necrosis Treatment Market Restraints
Table 18. Global Renal Cortical Necrosis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Renal Cortical Necrosis Treatment Market Share by Players (2020-2025)
Table 20. Global Top Renal Cortical Necrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Cortical Necrosis Treatment as of 2024)
Table 21. Ranking of Global Top Renal Cortical Necrosis Treatment Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Renal Cortical Necrosis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Renal Cortical Necrosis Treatment, Headquarters and Area Served
Table 24. Global Key Players of Renal Cortical Necrosis Treatment, Product and Application
Table 25. Global Key Players of Renal Cortical Necrosis Treatment, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Renal Cortical Necrosis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Renal Cortical Necrosis Treatment Revenue Market Share by Type (2020-2025)
Table 29. Global Renal Cortical Necrosis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Renal Cortical Necrosis Treatment Revenue Market Share by Type (2026-2031)
Table 31. Global Renal Cortical Necrosis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Renal Cortical Necrosis Treatment Revenue Market Share by Application (2020-2025)
Table 33. Global Renal Cortical Necrosis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Renal Cortical Necrosis Treatment Revenue Market Share by Application (2026-2031)
Table 35. North America Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Renal Cortical Necrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Renal Cortical Necrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Renal Cortical Necrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Renal Cortical Necrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Renal Cortical Necrosis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Renal Cortical Necrosis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Renal Cortical Necrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Renal Cortical Necrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Renal Cortical Necrosis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Renal Cortical Necrosis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 50. Allergan plc Company Details
Table 51. Allergan plc Business Overview
Table 52. Allergan plc Renal Cortical Necrosis Treatment Product
Table 53. Allergan plc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 54. Allergan plc Recent Development
Table 55. Amgen Inc. Company Details
Table 56. Amgen Inc. Business Overview
Table 57. Amgen Inc. Renal Cortical Necrosis Treatment Product
Table 58. Amgen Inc. Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 59. Amgen Inc. Recent Development
Table 60. AstraZeneca plc Company Details
Table 61. AstraZeneca plc Business Overview
Table 62. AstraZeneca plc Renal Cortical Necrosis Treatment Product
Table 63. AstraZeneca plc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 64. AstraZeneca plc Recent Development
Table 65. Baxter Company Details
Table 66. Baxter Business Overview
Table 67. Baxter Renal Cortical Necrosis Treatment Product
Table 68. Baxter Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 69. Baxter Recent Development
Table 70. Keryx Biopharmaceuticals, Inc Company Details
Table 71. Keryx Biopharmaceuticals, Inc Business Overview
Table 72. Keryx Biopharmaceuticals, Inc Renal Cortical Necrosis Treatment Product
Table 73. Keryx Biopharmaceuticals, Inc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 74. Keryx Biopharmaceuticals, Inc Recent Development
Table 75. Teva Pharmaceutical Limited Inc Company Details
Table 76. Teva Pharmaceutical Limited Inc Business Overview
Table 77. Teva Pharmaceutical Limited Inc Renal Cortical Necrosis Treatment Product
Table 78. Teva Pharmaceutical Limited Inc Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 79. Teva Pharmaceutical Limited Inc Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Renal Cortical Necrosis Treatment Product
Table 83. Pfizer Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 84. Pfizer Recent Development
Table 85. Novartis AG Company Details
Table 86. Novartis AG Business Overview
Table 87. Novartis AG Renal Cortical Necrosis Treatment Product
Table 88. Novartis AG Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 89. Novartis AG Recent Development
Table 90. Eisai Pharmaceuticals India Pvt. Ltd. Company Details
Table 91. Eisai Pharmaceuticals India Pvt. Ltd. Business Overview
Table 92. Eisai Pharmaceuticals India Pvt. Ltd. Renal Cortical Necrosis Treatment Product
Table 93. Eisai Pharmaceuticals India Pvt. Ltd. Revenue in Renal Cortical Necrosis Treatment Business (2020-2025) & (US$ Million)
Table 94. Eisai Pharmaceuticals India Pvt. Ltd. Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Authors List of This Report
List of Figures
Figure 1. Renal Cortical Necrosis Treatment Picture
Figure 2. Global Renal Cortical Necrosis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Renal Cortical Necrosis Treatment Market Share by Type: 2024 VS 2031
Figure 4. Prednisolone Features
Figure 5. Aspirin Features
Figure 6. Sodium Bicarbonates Features
Figure 7. N-acetyl Cysteine Features
Figure 8. Statins Features
Figure 9. Others Features
Figure 10. Global Renal Cortical Necrosis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Renal Cortical Necrosis Treatment Market Share by Application: 2024 VS 2031
Figure 12. Hospitals Case Studies
Figure 13. Cancer clinics Case Studies
Figure 14. Ambulatory Surgical Centers Case Studies
Figure 15. Others Case Studies
Figure 16. Renal Cortical Necrosis Treatment Report Years Considered
Figure 17. Global Renal Cortical Necrosis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Renal Cortical Necrosis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Renal Cortical Necrosis Treatment Market Share by Region: 2024 VS 2031
Figure 20. Global Renal Cortical Necrosis Treatment Market Share by Players in 2024
Figure 21. Global Top Renal Cortical Necrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Cortical Necrosis Treatment as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Renal Cortical Necrosis Treatment Revenue in 2024
Figure 23. North America Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Renal Cortical Necrosis Treatment Market Share by Country (2020-2031)
Figure 25. United States Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Renal Cortical Necrosis Treatment Market Share by Country (2020-2031)
Figure 29. Germany Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Renal Cortical Necrosis Treatment Market Share by Region (2020-2031)
Figure 37. China Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Renal Cortical Necrosis Treatment Market Share by Country (2020-2031)
Figure 45. Mexico Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Renal Cortical Necrosis Treatment Market Share by Country (2020-2031)
Figure 49. Turkey Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Renal Cortical Necrosis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Allergan plc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 53. Amgen Inc. Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 54. AstraZeneca plc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 55. Baxter Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 56. Keryx Biopharmaceuticals, Inc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 57. Teva Pharmaceutical Limited Inc Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 59. Novartis AG Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 60. Eisai Pharmaceuticals India Pvt. Ltd. Revenue Growth Rate in Renal Cortical Necrosis Treatment Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232